6-methoxy-3-p-tolylchromen-2-one | 949580-62-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 英文名称: 6-methoxy-3-p-tolylchromen-2-one
• 英文别名: 6-methoxy-3-p-tolyl-2H-chromen-2-one；6-methoxy-3-(4-methylphenyl)coumarin；6-Methoxy-3-(4-methylphenyl)chromen-2-one
• CAS: 949580-62-5
• 化学式: C₁₇H₁₄O₃
• 分子量: 266.296
• InChiKey: DGCAQQRTNOKFHK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-methoxy-3-p-tolylchromen-2-one 在 氢碘酸 、 乙酸酐 、 potassium carbonate 、 溶剂黄146 作用下， 以 丙酮 为溶剂， 反应 27.0h， 生成 6-(2-cyclopentyloxy)-3-(4-methylphenyl)coumarin
  参考文献：
  名称：

  Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors

  摘要：

  New series of 6-substituted-3-arylcoumarins displaying several alkyl, hydroxyl, halogen, and alkoxy groups in the two benzene rings have been designed, synthesized, and evaluated in vitro as human monoamine cuddase A and B (hMAO-A and hMAO-B) inhibitors. Most of the studied compounds showed a high affinity and selectivity to the hMAO-B isoenzyme, with IC50 values on nanomolar and picomolar range. Ten of the 22 described compounds displayed higher MAO-B inhibitory activity and selectivity than selegiline. Coumarin 7 is the most active compound of this series, being 64 times more active than selegiline and also showing the highest hMAO-B specificity. In addition, docking experiments were carried out on hMAO-A and h-MAO-B structures. This study provided new information about the enzyme inhibitor interaction and the potential therapeutic application of this 3-arylcoumarin scaffold.

  DOI：

  10.1021/jm200716y
• 作为产物：
  描述：

  2-羟基-5-甲氧基苯甲醛 、 对甲基苯乙酸 在 N,N'-二环己基碳二亚胺 作用下， 以 二甲基亚砜 为溶剂， 反应 24.0h， 以76%的产率得到6-methoxy-3-p-tolylchromen-2-one
  参考文献：
  名称：

  Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors

  摘要：

  New series of 6-substituted-3-arylcoumarins displaying several alkyl, hydroxyl, halogen, and alkoxy groups in the two benzene rings have been designed, synthesized, and evaluated in vitro as human monoamine cuddase A and B (hMAO-A and hMAO-B) inhibitors. Most of the studied compounds showed a high affinity and selectivity to the hMAO-B isoenzyme, with IC50 values on nanomolar and picomolar range. Ten of the 22 described compounds displayed higher MAO-B inhibitory activity and selectivity than selegiline. Coumarin 7 is the most active compound of this series, being 64 times more active than selegiline and also showing the highest hMAO-B specificity. In addition, docking experiments were carried out on hMAO-A and h-MAO-B structures. This study provided new information about the enzyme inhibitor interaction and the potential therapeutic application of this 3-arylcoumarin scaffold.

  DOI：

  10.1021/jm200716y

文献信息

• Visible-light-driven copper-catalyzed aerobic oxidative cascade cyclization of <i>N</i>-tosylhydrazones and terminal alkynes: regioselective synthesis of 3-arylcoumarins
  作者：Ayyakkannu Ragupathi、Arunachalam Sagadevan、Vaibhav Pramod Charpe、Chun-Cheng Lin、Jih-Ru Hwu、Kuo Chu Hwang

  DOI：10.1039/c9cc01801h

  日期：——

  first example of sustainable, intuitive, highly regioselective, visible-light-driven copper catalyzed aerobic oxidative cascade cyclization of N-tosylhydrazones with terminal alkynes for the preparation of 3-arylcoumarins at room temperature. This operationally simple methodology has been successfully applied to a wide range of N-tosylhydrazones and alkynes (49 examples), and proceeds well to afford biologically

  我们提出了可持续的，直观的，高度区域选择性的，可见光驱动的铜催化的N-甲苯磺酰with与末端炔烃的有氧氧化级联环化反应，以在室温下制备3-芳基香豆素。这种操作简单的方法已成功应用于各种N-甲苯磺酰hydr和炔烃（49个实例），并且进展顺利，可提供具有生物活性的化合物，例如单胺氧化酶B（MAO-B）抑制剂和辣根过氧化物酶（HRP）抑制剂，在温和的条件下具有令人满意的产量。此外，机理研究表明，反应是通过铜进行的（II18 O 2同位素标记实验证明）-超氧或-过氧配合物介导的末端炔烃的氧化环化反应。
• Extensive SAR and Computational Studies of 3-{4-[(Benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) Derivatives
  作者：Lorna Piazzi、Andrea Cavalli、Federica Belluti、Alessandra Bisi、Silvia Gobbi、Stefano Rizzo、Manuela Bartolini、Vincenza Andrisano、Maurizio Recanatini、Angela Rampa

  DOI：10.1021/jm070100g

  日期：2007.8.1

  AP2238 was the first compound published to bind both anionic sites of the human acetylcholinesterase, allowing the simultaneous inhibition of the catalytic and the amyloid-beta pro-aggregating activities of AChE. Here we attempted to derive a comprehensive structure-activity relationship picture for this molecule, affording 28 derivatives for which AChE and BChE inhibitory activities were evaluated. Selected compounds were also tested for their ability to prevent the AChE-induced A beta-aggregation. Moreover, docking simulations and molecular orbital calculations were performed.